CA9 and cancer: Hybrids as those shown in Figure 11, incorporating aromatic/heterocyclic sulphonamides as CA inhibitory chemotype, possessed low nanomolar affinity for CA IX as well as in vivo activity, in SK-RC-52 renal cell carcinoma cancer xenograft models of cancer in experimental animals59–61,.63